Abstract
Educating physicians in interventional procedures relies on relatively few simulants, or patients. In the pediatric population a comparative lack of simulants may force providers to revert to ‘see one, do one, teach one’ when it comes to congenital anomalies. Rare or unique anomalies would be unlikely to ever be available commercially. Therefore, the capability of producing high fidelity simulants is a potentially great benefit for pediatric simulation.
